Arch Biopartners, Inc. (ARCH.V)
0.87
0.00 (0.00%)
CAD |
TSXV |
Oct 23, 16:00
Arch Biopartners Shareholders Equity (Quarterly) : -3.986M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.986M |
| March 31, 2026 | -3.644M |
| December 31, 2025 | -3.599M |
| September 30, 2025 | -3.882M |
| June 30, 2025 | -3.658M |
| March 31, 2025 | -3.768M |
| December 31, 2024 | -4.260M |
| September 30, 2024 | -4.348M |
| June 30, 2024 | -6.557M |
| March 31, 2024 | -6.435M |
| December 31, 2023 | -5.713M |
| September 30, 2023 | -5.510M |
| June 30, 2023 | -5.754M |
| March 31, 2023 | -5.431M |
| December 31, 2022 | -4.469M |
| September 30, 2022 | -4.471M |
| June 30, 2022 | -3.973M |
| March 31, 2022 | -3.910M |
| December 31, 2021 | -4.045M |
| September 30, 2021 | -3.882M |
| June 30, 2021 | -4.821M |
| March 31, 2021 | -5.716M |
| December 31, 2020 | -4.791M |
| September 30, 2020 | -3.868M |
| June 30, 2020 | -2.608M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.396M |
| December 31, 2019 | -3.488M |
| September 30, 2019 | -2.902M |
| June 30, 2019 | -2.273M |
| March 31, 2019 | -2.270M |
| December 31, 2018 | -1.832M |
| September 30, 2018 | -1.046M |
| June 30, 2018 | -0.2746M |
| March 31, 2018 | -0.2539M |
| December 31, 2017 | -0.9052M |
| September 30, 2017 | -0.5634M |
| June 30, 2017 | -0.5276M |
| March 31, 2017 | -0.2498M |
| December 31, 2016 | -0.4923M |
| September 30, 2016 | -0.2569M |
| June 30, 2016 | -0.0466M |
| March 31, 2016 | -0.1911M |
| December 31, 2015 | 0.0039M |
| September 30, 2015 | 0.1415M |
| June 30, 2015 | 0.3245M |
| March 31, 2015 | 0.4889M |
| December 31, 2014 | -0.158M |
| September 30, 2014 | -0.0066M |
| June 30, 2014 | -0.2829M |
| March 31, 2014 | -0.152M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Innovotech, Inc. | 2.543M |
| Kane Biotech, Inc. | -0.9939M |
| Quest PharmaTech, Inc. | 26.43M |
| BriaCell Therapeutics Corp. | 32.75M |
| Vaxil Bio Ltd. | 1.194M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0572M |
| Total Liabilities (Quarterly) | 4.043M |
| Debt to Equity Ratio | -0.6842 |
| Current Ratio | 0.0141 |
| Net Debt Paydown Yield | 0.05% |